Consolidated Financial Results for the 3rd
Quarter of Fiscal 2018 and Full-Year Forecasts

from the beginning

Consolidated Financial Results for the 3rd Quarter of Fiscal 2018 and Full-Year Forecasts

Disclaimer

Voluntary Adoption of IFRS

Highlights

Consolidated Financial Results and Business Overview for the 3Q of Fiscal 2018 (FY Ending March 31, 2018)

3Q of Fiscal 2018 (1) Consolidated Financial Results

3Q of Fiscal 2018 (1) Factors Influences Consolidated Operating Profit

3Q of Fiscal 2018 (2) Results by Business Segment

3Q of Fiscal 2018 (2) Medical Business

3Q of Fiscal 2018 (3) Medical Business

3Q of Fiscal 2018 (4) Scientific Solutions Business

3Q of Fiscal 2018 (5) Imaging Business

Statement of Financial Position

Consolidated Cash Flows

Forecast for Fiscal 2018

Forecasts of Consolidated Financial Results for Fiscal 2018

Segment Forecasts for fiscal 2018

@

Appendix

【Supplementary Materials】 R&D Expenditures

【Supplementary Materials】 Forecasts of Consolidated Financial Results for Fiscal 2018 (Full-year basis) Factors Influences Consolidated Operating Profit(YoY)

【Supplementary Materials (JGAAP/IFRS) 】 FY2017 3Q Results (1) Consolidated

【Supplementary Materials (JGAAP/IFRS) 】 FY2017 3Q Results (2) Factors Influencing OP

【Supplementary Materials (JGAAP/IFRS) 】 FY2017 3Q Results (3) Factors Influencing Profit

【Supplementary Materials (JGAAP/IFRS) 】 FY2017 3Q Results (4) By segment

【Supplementary Materials (JGAAP/IFRS) 】 FY2017 Full Year Results (1) Consolidated

【Supplementary Materials (JGAAP/IFRS) 】 FY2017 Full Year Results (2) Factors Influencing Operating Profit

【Supplementary Materials (JGAAP/IFRS) 】 FY2017 Full Year Results (3) Factors Influencing Profit

【Supplementary Materials (JGAAP/IFRS) 】 FY2017 Full Year Results (4) By segment

Q&A

• Q&A 1

• Q&A 2

• Q&A 3

• Q&A 4

• Q&A 5

• Q&A 6

• Q&A 7